A Day Up For Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc. (ARMP:NYSEMKT) shot up at $2.74, a gain of 39.1%. On Wed, Jul 26, 2023, ARMP:NYSEMKT hit a New 2-Week High of $2.74. From Wed, Jul 12, 2023, the stock recorded 70.00% Up Days and 36.36% Green Days
About Armata Pharmaceuticals Inc. (ARMP:NYSEMKT)
Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.
Top 10 Gainers:
- Mallinckrodt plc (MNK:NYSEMKT), 186.36%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 166.67%
- Vicor Corporation (VICR:NASDAQ), 57.72%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- AERWINS Technologies Inc Com (AWIN:NASDAQ), 44.93%
- Tupperware Brands Corporation (TUP:NYSE), 42.86%
- Aceragen Inc Com (ACGN:NASDAQ), 42.06%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 39.09%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 38.41%
- SCWorx Corp. (WORX:NASDAQ), 33.44%